Table 3. Timing to the occurrence of myelosuppression AEs.
| AEs | Grade ≥1 AE, n (%) | |
|---|---|---|
| 0–3 months | 3–6 months | |
| Leukopenia (n=16) | 15 (93.8) | 1 (6.3) |
| Anemia (n=15) | 12 (80.0) | 3 (20.0) |
| Thrombocytopenia (n=17) | 13 (76.5) | 4 (23.5) |
AE, adverse event.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.